Abstract

Simple SummaryLactobacillus reuteri DSM 17938 is beneficial for reduction of crying time in infantile colic, as demonstrated through multiple randomized controlled clinical trials. This clinic-based real-life study is the first to evaluate the role of L. reuteri DSM 17938 in infantile colic in India. We observed that L. reuteri DSM 17938 supplementation in infantile colic subjects resulted in a significant reduction of crying time and unexplained fussiness. A significant number of subjects reported 50% reduction in crying time throughout the study duration. There was also a significant reduction in maternal depression scores, from baseline to study end. Background: Infantile colic is characterized by prolonged periods of inconsolable, incessant crying and persistent fussing in an otherwise healthy infant. It is a self-limiting condition, but causes significant stress to mothers. AIM: To observe the role of Lactobacillus reuteri DSM 17938 in reducing crying time in colicky infants in routine clinical practice. Methods: This was a prospective observational multicentric clinic-based study. Each practitioner included approximately 30 infants < 5 months of age with infantile colic who were prescribed L. reuteri DSM 17938 for a period of 21 days. There were four physical consultations and two telephonic consultations. The parents were given a daily diary to record the duration of crying and fussing episodes and a questionnaire was administered during the consultations. Results: A total of 120 infants with a mean age of 56.9 ± 34.2 days were included in this 28-day study. The mean crying time as reported by the parents in the subject diary reduced from 248.2 ± 101.2 min, 95% CI: 229.45, 266.94 at baseline to 45.6 ± 79.1 min 95% CI: 31.02, 60.31 at study end (P < 0.01). The clinical response (defined as reduction of 50% in crying time) was observed in 85% of subjects at study end. The fussiness and parental perception of colic recorded during the consultations were reduced by 66% and 72%, respectively, at study end. The maternal depression scores were reduced to 63% at study end. Conclusion: L. reuteri DSM 17938 was associated with a significant reduction in crying time in colicky infants, and showed improvement in maternal depression.

Highlights

  • Infantile colic is defined as recurrent prolonged periods of irritability, fussing, or crying in infants reported by parents, and occurring without any obvious cause

  • Numerous placebo-controlled studies have demonstrated that administration of L. reuteri DSM 17938 can significantly reduce crying time in infants with colic, and in such the response rates of having a 50% or greater decrease in crying/fussing time were 2.3-fold greater compared to controls [3,4,5]

  • Numerous studies have evaluated the association of infantile colic and maternal depression that results in increased risk of maternal anxiety, child abuse, and early cessation of breastfeeding [8,9]

Read more

Summary

Introduction

Infantile colic is defined as recurrent prolonged periods of irritability, fussing, or crying in infants reported by parents, and occurring without any obvious cause. Infantile colic is characterized by prolonged periods of inconsolable, incessant crying and persistent fussing in an otherwise healthy infant It is a self-limiting condition, but causes significant stress to mothers. AIM: To observe the role of Lactobacillus reuteri DSM 17938 in reducing crying time in colicky infants in routine clinical practice. The mean crying time as reported by the parents in the subject diary reduced from 248.2 ± 101.2 min, 95% CI: 229.45, 266.94 at baseline to 45.6 ± 79.1 min 95% CI: 31.02, 60.31 at study end (P < 0.01). Conclusion: L. reuteri DSM 17938 was associated with a significant reduction in crying time in colicky infants, and showed improvement in maternal depression

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.